Epigamia Secures ₹167 Crore in Secondary Deal; Verlinvest, Mirchandani Family Boost Stakes
Source: Mint Companies
Arth Insight · What this means for your wallet
- Epigamia secured approximately ₹167 crore ($20 million) in a secondary funding round.
- Existing investors Verlinvest and the Mirchandani family have increased their ownership in the company.
- Venture capital firm Sauce has joined Epigamia's investor group.
Dairy and snacking brand Epigamia has raised approximately ₹167 crore ($20 million) in a secondary funding round. Existing investors Verlinvest and the Mirchandani family increased their stakes, while new investor Sauce joined the cap table. This move supports Epigamia's goal to double its business every 24-30 months.
- ▸Epigamia secured approximately ₹167 crore ($20 million) in a secondary funding round.
- ▸Existing investors Verlinvest and the Mirchandani family have increased their ownership in the company.
- ▸Venture capital firm Sauce has joined Epigamia's investor group.
- ▸The profitable dairy and snacking brand aims to double its business within 24-30 months.
- ✓Epigamia secured approximately ₹167 crore ($20 million) in a secondary funding round.
- ✓Existing investors Verlinvest and the Mirchandani family have increased their ownership in the company.
- ✓Venture capital firm Sauce has joined Epigamia's investor group.
- ✓The profitable dairy and snacking brand aims to double its business within 24-30 months.
Epigamia, the popular Indian dairy and snacking startup, has successfully secured approximately ₹167 crore (equivalent to $20 million at current exchange rates) in a secondary funding deal. This significant transaction saw existing major investors, including global consumer-focused private equity firm Verlinvest and the Mirchandani founder family, increase their stakes in the company. Additionally, new venture capital firm Sauce has joined Epigamia’s capital table, diversifying its investor base.
A 'secondary deal' fundamentally differs from a primary funding round where fresh capital is injected into a company. In a secondary transaction, shares are purchased from existing investors or founders, rather than new money going directly into the company’s coffers for operational expansion or growth initiatives. Such deals often indicate strong investor confidence in a company's profitability and future potential, allowing early backers to realise returns while attracting new strategic partners.
Profitable Growth and Ambitious Targets
Known for its range of Greek yogurts and other healthy snack products, Epigamia has successfully established itself as a profitable entity within India's highly competitive consumer goods market. The company has articulated ambitious growth targets, aiming to double its business operations within the next 24 to 30 months. This goal reflects its strong market traction and a strategic vision for continued expansion in the evolving Indian snacking landscape.
Verlinvest has been a consistent supporter of Epigamia, backing its growth journey over the years. The increased commitment from the Mirchandani family, closely associated with the company's origins, further underscores their belief in Epigamia's long-term prospects. The inclusion of Sauce as a new investor brings additional strategic perspective and capital support to the dairy and snacking brand.
What This Means for Retail Readers
For Indian retail readers, this funding round serves as a key indicator of continued investor appetite for profitable, consumer-centric startups. It highlights a positive trend within the broader venture capital and private equity landscape, where companies demonstrating clear pathways to profitability and strong market presence are successfully attracting substantial capital. While this news does not present a direct investment opportunity for individual retail investors, it offers valuable insights into the health of the Indian startup ecosystem and signals which brands are gaining significant investor trust and aiming for substantial growth.
This article is for informational purposes only and not investment advice.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
What is a secondary deal in startup funding?
A secondary deal involves existing investors buying shares from other existing shareholders or founders, rather than fresh capital being injected into the company for operations or growth. It often indicates strong confidence in the company's future.
Who are the key investors in Epigamia?
Verlinvest and the Mirchandani family (founder family) are significant existing investors who have increased their stakes. Sauce is a new investor joining the company's cap table.
What are Epigamia's growth plans?
The profitable dairy and snacking startup aims to double its business within a period of 24 to 30 months.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Stock Market
IPOBreakingMolbio Diagnostics Surges 83% Since Listing: Motilal Oswal Issues 'Buy' Rating
Molbio Diagnostics has delivered massive returns of over 80% within two months of its stock market debut. Brokerage firm Motilal Oswal remains bullish on the stock, citing strong growth potential despite the recent price rally.
BreakingNifty 50 Gains 0.56%, Sensex Rises 426 Points by 2 PM; IT and Auto Sectors Lag
The Indian equity market saw robust gains in afternoon trading, with the Nifty 50 index climbing 0.56% and the Sensex advancing by 426 points by 2 PM. Despite the overall positive momentum, shares in the Information Technology (IT) and Automobile sectors experienced underperformance, weighing on broader market gains.
BreakingShort-Term Stock Picks: Experts Suggest Aditya Infotech, Thyrocare, MIDHANI & More
As the Nifty 50 index shows signs of recovery amidst falling crude oil prices, market experts have identified six specific stocks with potential for short-term gains. These recommendations include companies like Aditya Infotech, Thyrocare, and MIDHANI, along with suggestions for target prices and crucial stop-loss levels for investors.
Related Stories
IPOBreakingMolbio Diagnostics Surges 83% Since Listing: Motilal Oswal Issues 'Buy' Rating
Molbio Diagnostics has delivered massive returns of over 80% within two months of its stock market debut. Brokerage firm Motilal Oswal remains bullish on the stock, citing strong growth potential despite the recent price rally.
BreakingNifty 50 Gains 0.56%, Sensex Rises 426 Points by 2 PM; IT and Auto Sectors Lag
The Indian equity market saw robust gains in afternoon trading, with the Nifty 50 index climbing 0.56% and the Sensex advancing by 426 points by 2 PM. Despite the overall positive momentum, shares in the Information Technology (IT) and Automobile sectors experienced underperformance, weighing on broader market gains.
BreakingShort-Term Stock Picks: Experts Suggest Aditya Infotech, Thyrocare, MIDHANI & More
As the Nifty 50 index shows signs of recovery amidst falling crude oil prices, market experts have identified six specific stocks with potential for short-term gains. These recommendations include companies like Aditya Infotech, Thyrocare, and MIDHANI, along with suggestions for target prices and crucial stop-loss levels for investors.
BreakingSEBI's Social Media Campaign Boosts Investor Awareness on X, Featuring Top Market Bodies
The Securities and Exchange Board of India (SEBI) recently spearheaded an investor awareness 'teaser campaign' on social media platform X (formerly Twitter). The initiative, aimed at educating retail investors, garnered significant attention with active participation from major Indian stock exchanges, depositories, and the mutual fund industry body.